Boston, MA
Lusaris Therapeutics develops small-molecule neuroplastogen therapeutics for neuropsychiatric and neurological disorders.
lusaristx.comThese are collections Lusaris Therapeutics is a part of. Click on the collection name to view similar companies.
Series A
$60,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Lusaris Therapeutics.